作者:
Sokol,L. [1]
;
Cripe,L. [2]
;
Kantarjian,H. [3]
;
Sekeres,M.A. [4]
;
Parmar,S. [5]
;
Greenberg,P. [6]
;
Goldberg,S.L. [7]
;
Bhushan,V. [8]
;
Shammo,J. [9]
;
Hohl,R. [10]
;
Verma,A. [11]
;
Garcia-Manero,G. [12]
;
Li,Y.-P. ;
Lowe,A. ;
Zhu,J. ;
List,A.F.
作者单位:
Department of Internal Medicine, University of Iowa, Iowa City, IA, United States
[1]
Dallas VA Medical Center, Dallas, TX, United States
[2]
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, United States
[3]
Department of Medicine, Indiana University Cancer Center, Indianapolis, IN, United States
[4]
Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Foundation Taussig Cancer
[5]
Department of Medicine, John Theurer Cancer Center of Hackensack, University Medical Center
[6]
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
[7]
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States
[8]
Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States
[9]
SCIOS Inc., Fremont, CA, United States
[10]
Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
[11]
Department of Medicine, Stanford University Medical Center, Stanford, CA, United States
[12]
发布时间
2013-11-20